市場調查報告書

全球癌症/腫瘤分析市場

Cancer/Tumor Profiling

出版商 Global Industry Analysts, Inc. 商品編碼 893731
出版日期 內容資訊 英文 193 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球癌症/腫瘤分析市場 Cancer/Tumor Profiling
出版日期: 2019年07月01日內容資訊: 英文 193 Pages
簡介

本報告提供全球癌症/腫瘤分析市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 全球競爭企業的市場佔有率
    • 市場佔有率方案
    • 免疫化驗
    • 混合化
    • 次世代定序
    • 質譜分析
  • 主要參與企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他各國

第4章 競爭

  • CARIS LIFE SCIENCES
  • GENOMIC HEALTH
  • HTG MOLECULAR DIAGNOSTICS
  • HELOMICS
  • ILLUMINA
  • NANOSTRING TECHNOLOGIES
  • NEOGENOMICS LABORATORIES
  • OXFORD GENE TECHNOLOGY
  • QIAGEN NV
  • RIBOMED BIOTECHNOLOGIES, INC.

第5章 相關調查

目錄
Product Code: MCP10868

Cancer/Tumor Profiling market worldwide is projected to grow by US$5.6 Billion, driven by a compounded growth of 10.4%. Immunoassays, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.5 Billion by the year 2025, Immunoassays will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$251.8 Million to the region's size and clout in the next 5 to 6 years. Over US$554.8 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Immunoassays will reach a market size of US$319 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 9.9% over the next couple of years and add approximately US$952.3 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Caris Life Sciences (USA); Genomic Health, Inc. (USA); Helomics® Corporation (USA); HTG Molecular Diagnostics, Inc. (USA); Illumina, Inc. (USA); Nanostring Technologies, Inc. (USA); NeoGenomics Laboratories, Inc. (USA); Oxford Gene Technology (United Kingdom); Qiagen NV (The Netherlands); Ribomed Biotechnologies, Inc. (USA)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Cancer/Tumor Profiling Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Global Competitor Market Shares by Segment
  • Immunoassays (Technology) Global Competitor Market Share Positioning for 2019 & 2025
  • Hybridization (Technology) Market Share Breakdown of Key Players: 2019 & 2025
  • Next Generation Sequencing (Technology) Competitor Revenue Share (in %): 2019 & 2025
  • Mass Spectrometry (Technology) Market Share Shift by Company: 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Cancer/Tumor Profiling Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Cancer/Tumor Profiling Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Cancer/Tumor Profiling Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Clinical Application (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
  • TABLE 5: Clinical Application (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
  • TABLE 6: Clinical Application (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
  • TABLE 7: Research Application (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 8: Research Application (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 9: Research Application (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 10: Immunoassays (Technology) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 11: Immunoassays (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 12: Immunoassays (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Hybridization (Technology) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 14: Hybridization (Technology) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Hybridization (Technology) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 16: Next Generation Sequencing (Technology) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 17: Next Generation Sequencing (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 18: Next Generation Sequencing (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Mass Spectrometry (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 20: Mass Spectrometry (Technology) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Mass Spectrometry (Technology) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Other Technologies (Pyrosequencing and Sanger Sequencing) (Technology) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 23: Other Technologies (Pyrosequencing and Sanger Sequencing) (Technology) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 24: Other Technologies (Pyrosequencing and Sanger Sequencing) (Technology) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Breast Cancer (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 26: Breast Cancer (Cancer Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 27: Breast Cancer (Cancer Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Lung Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
  • TABLE 29: Lung Cancer (Cancer Type) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
  • TABLE 30: Lung Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 31: Colorectal Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 32: Colorectal Cancer (Cancer Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 33: Colorectal Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 34: Prostate Cancer (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 35: Prostate Cancer (Cancer Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 36: Prostate Cancer (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 37: Melanoma Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 38: Melanoma Cancer (Cancer Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 39: Melanoma Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 40: Other Cancer Types (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 41: Other Cancer Types (Cancer Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 42: Other Cancer Types (Cancer Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cancer/Tumor Profiling Market Share (in %) by Company: 2019 & 2025
    • Immunoassays (Technology) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
    • Hybridization (Technology) Competitor Revenue Share (in %) in the US: 2019 & 2025
    • Next Generation Sequencing (Technology) Market Share Breakdown (in %) of Major Players in the US: 2019 & 2025
    • Mass Spectrometry (Technology) Market in the US: Percentage Breakdown of Revenues by Company for 2019 & 2025
    • TABLE 43: United States Cancer/Tumor Profiling Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 44: Cancer/Tumor Profiling Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
    • TABLE 45: Cancer/Tumor Profiling Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
    • TABLE 46: Cancer/Tumor Profiling Market in US$ Million in the United States by Technology: 2018-2025
    • TABLE 47: United States Cancer/Tumor Profiling Market Retrospective Analysis in US$ Million by Technology: 2009-2017
    • TABLE 48: United States Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
    • TABLE 49: United States Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Cancer Type: 2018 to 2025
    • TABLE 50: Cancer/Tumor Profiling Market in the United States by Cancer Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 51: United States Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 52: Canadian Cancer/Tumor Profiling Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 53: Cancer/Tumor Profiling Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 54: Canadian Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025
    • TABLE 55: Cancer/Tumor Profiling Market Analysis in Canada in US$ Million by Technology: 2018-2025
    • TABLE 56: Cancer/Tumor Profiling Market in Canada: Historic Review in US$ Million by Technology for the Period 2009-2017
    • TABLE 57: Canadian Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
    • TABLE 58: Canadian Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025
    • TABLE 59: Canadian Cancer/Tumor Profiling Historic Market Review by Cancer Type in US$ Million: 2009-2017
    • TABLE 60: Cancer/Tumor Profiling Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 61: Japanese Demand Estimates and Forecasts for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025
    • TABLE 62: Japanese Cancer/Tumor Profiling Market in US$ Million by Application: 2009-2017
    • TABLE 63: Cancer/Tumor Profiling Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
    • TABLE 64: Japanese Medium & Long-Term Outlook for Cancer/Tumor Profiling Market in US$ Million by Technology: 2018-2025
    • TABLE 65: Cancer/Tumor Profiling Market in Japan in US$ Million by Technology: 2009-2017
    • TABLE 66: Japanese Cancer/Tumor Profiling Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025
    • TABLE 67: Japanese Market for Cancer/Tumor Profiling: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the period 2018-2025
    • TABLE 68: Cancer/Tumor Profiling Market in Japan: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017
    • TABLE 69: Japanese Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 70: Chinese Demand for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025
    • TABLE 71: Cancer/Tumor Profiling Market Review in China in US$ Million by Application: 2009-2017
    • TABLE 72: Chinese Cancer/Tumor Profiling Market Share Breakdown by Application: 2009 VS 2019 VS 2025
    • TABLE 73: Cancer/Tumor Profiling Market Estimates and Forecasts in China in US$ Million by Technology: 2018-2025
    • TABLE 74: Chinese Cancer/Tumor Profiling Retrospective Market Scenario in US$ Million by Technology: 2009-2017
    • TABLE 75: Cancer/Tumor Profiling Market in China: Percentage Share Analysis by Technology for 2009, 2019, and 2025
    • TABLE 76: Chinese Cancer/Tumor Profiling Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025
    • TABLE 77: Cancer/Tumor Profiling Historic Market Analysis in China in US$ Million by Cancer Type: 2009-2017
    • TABLE 78: Chinese Cancer/Tumor Profiling Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Cancer/Tumor Profiling Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Immunoassays (Technology) Market Share (in %) by Company in Europe: 2019 & 2025
    • Hybridization (Technology) Market Share (in %) of Major Players in Europe: 2019 & 2025
    • Next Generation Sequencing (Technology) Competitor Market Share Analysis (in %) in Europe: 2019 & 2025
    • Mass Spectrometry (Technology) Market in Europe: Competitor Revenue Share Shift (in %) for 2019 & 2025
    • TABLE 79: European Cancer/Tumor Profiling Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 80: Cancer/Tumor Profiling Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 81: European Cancer/Tumor Profiling Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 82: European Cancer/Tumor Profiling Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 83: Cancer/Tumor Profiling Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 84: European Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025
    • TABLE 85: European Cancer/Tumor Profiling Market Assessment in US$ Million by Technology: 2018-2025
    • TABLE 86: European Cancer/Tumor Profiling Historic Market Review in US$ Million by Technology: 2009-2017
    • TABLE 87: Cancer/Tumor Profiling Market in Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025
    • TABLE 88: European Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025
    • TABLE 89: Cancer/Tumor Profiling Market in Europe in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017
    • TABLE 90: European Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 91: Cancer/Tumor Profiling Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
    • TABLE 92: French Cancer/Tumor Profiling Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 93: French Cancer/Tumor Profiling Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
    • TABLE 94: French Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Technology: 2018-2025
    • TABLE 95: French Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Technology: 2009-2017
    • TABLE 96: French Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
    • TABLE 97: Cancer/Tumor Profiling Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 98: French Cancer/Tumor Profiling Historic Market Scenario in US$ Million by Cancer Type: 2009-2017
    • TABLE 99: French Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 100: Cancer/Tumor Profiling Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 101: German Cancer/Tumor Profiling Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 102: Cancer/Tumor Profiling Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
    • TABLE 103: German Cancer/Tumor Profiling Latent Demand Forecasts in US$ Million by Technology: 2018-2025
    • TABLE 104: Cancer/Tumor Profiling Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2009-2017
    • TABLE 105: German Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
    • TABLE 106: Cancer/Tumor Profiling Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2018-2025
    • TABLE 107: German Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Cancer Type: 2009-2017
    • TABLE 108: German Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 109: Italian Demand for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025
    • TABLE 110: Cancer/Tumor Profiling Market Review in Italy in US$ Million by Application: 2009-2017
    • TABLE 111: Italian Cancer/Tumor Profiling Market Share Breakdown by Application: 2009 VS 2019 VS 2025
    • TABLE 112: Cancer/Tumor Profiling Market Estimates and Forecasts in Italy in US$ Million by Technology: 2018-2025
    • TABLE 113: Italian Cancer/Tumor Profiling Retrospective Market Scenario in US$ Million by Technology: 2009-2017
    • TABLE 114: Cancer/Tumor Profiling Market in Italy: Percentage Share Analysis by Technology for 2009, 2019, and 2025
    • TABLE 115: Italian Cancer/Tumor Profiling Market Growth Prospects in US$ Million by Cancer Type for the Period 2018-2025
    • TABLE 116: Cancer/Tumor Profiling Historic Market Analysis in Italy in US$ Million by Cancer Type: 2009-2017
    • TABLE 117: Italian Cancer/Tumor Profiling Market by Cancer Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 118: United Kingdom Demand Estimates and Forecasts for Cancer/Tumor Profiling in US$ Million by Application: 2018 to 2025
    • TABLE 119: United Kingdom Cancer/Tumor Profiling Market in US$ Million by Application: 2009-2017
    • TABLE 120: Cancer/Tumor Profiling Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
    • TABLE 121: United Kingdom Medium & Long-Term Outlook for Cancer/Tumor Profiling Market in US$ Million by Technology: 2018-2025
    • TABLE 122: Cancer/Tumor Profiling Market in the United Kingdom in US$ Million by Technology: 2009-2017
    • TABLE 123: United Kingdom Cancer/Tumor Profiling Market Percentage Share Distribution by Technology: 2009 VS 2019 VS 2025
    • TABLE 124: United Kingdom Market for Cancer/Tumor Profiling: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the period 2018-2025
    • TABLE 125: Cancer/Tumor Profiling Market in the United Kingdom: Historic Sales Analysis in US$ Million by Cancer Type for the Period 2009-2017
    • TABLE 126: United Kingdom Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 127: Rest of Europe Cancer/Tumor Profiling Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 128: Cancer/Tumor Profiling Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 129: Rest of Europe Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025
    • TABLE 130: Rest of Europe Cancer/Tumor Profiling Market Assessment in US$ Million by Technology: 2018-2025
    • TABLE 131: Rest of Europe Cancer/Tumor Profiling Historic Market Review in US$ Million by Technology: 2009-2017
    • TABLE 132: Cancer/Tumor Profiling Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2009, 2019, and 2025
    • TABLE 133: Rest of Europe Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018-2025
    • TABLE 134: Cancer/Tumor Profiling Market in Rest of Europe in US$ Million by Cancer Type: A Historic Review for the Period 2009-2017
    • TABLE 135: Rest of Europe Cancer/Tumor Profiling Market Share Breakdown by Cancer Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 136: Cancer/Tumor Profiling Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
    • TABLE 137: Asia-Pacific Cancer/Tumor Profiling Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 138: Asia-Pacific Cancer/Tumor Profiling Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
    • TABLE 139: Asia-Pacific Cancer/Tumor Profiling Market Estimates and Projections in US$ Million by Technology: 2018-2025
    • TABLE 140: Asia-Pacific Cancer/Tumor Profiling Historic Market Analysis in US$ Million by Technology: 2009-2017
    • TABLE 141: Asia-Pacific Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
    • TABLE 142: Cancer/Tumor Profiling Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 143: Asia-Pacific Cancer/Tumor Profiling Historic Market Scenario in US$ Million by Cancer Type: 2009-2017
    • TABLE 144: Asia-Pacific Cancer/Tumor Profiling Market Share Analysis by Cancer Type: 2009 VS 2019 VS 2025
  • REST OF WORLD
    • TABLE 145: Rest of World Cancer/Tumor Profiling Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 146: Cancer/Tumor Profiling Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 147: Rest of World Cancer/Tumor Profiling Market Share Analysis by Application: 2009 VS 2019 VS 2025
    • TABLE 148: Cancer/Tumor Profiling Market Analysis in Rest of World in US$ Million by Technology: 2018-2025
    • TABLE 149: Cancer/Tumor Profiling Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2009-2017
    • TABLE 150: Rest of World Cancer/Tumor Profiling Market Share Breakdown by Technology: 2009 VS 2019 VS 2025
    • TABLE 151: Rest of World Cancer/Tumor Profiling Market Estimates and Forecasts in US$ Million by Cancer Type: 2018 to 2025
    • TABLE 152: Rest of World Cancer/Tumor Profiling Historic Market Review by Cancer Type in US$ Million: 2009-2017
    • TABLE 153: Cancer/Tumor Profiling Market in Rest of World: Percentage Share Breakdown of Sales by Cancer Type for 2009, 2019, and 2025

IV. COMPETITION

  • CARIS LIFE SCIENCES
  • GENOMIC HEALTH
  • HTG MOLECULAR DIAGNOSTICS
  • HELOMICS
  • ILLUMINA
  • NANOSTRING TECHNOLOGIES
  • NEOGENOMICS LABORATORIES
  • OXFORD GENE TECHNOLOGY
  • QIAGEN NV
  • RIBOMED BIOTECHNOLOGIES, INC.

V. CURATED RESEARCH

Back to Top